Skip to main content

Table 4 Smoking cessation monitoring according to group assignment*

From: The SCIDOTS Project: Evidence of benefits of an integrated tobacco cessation intervention in tuberculosis care on treatment outcomes

Monitoring parameter

DOTS

(n = 46)

SCIDOTS

(n = 40)

p-value†

Baseline (Week 0)

   

Breath CO (ppm)

7.61 ± 3.61

5.93 ± 2.83

0.020

FTND

5.43 ± 1.96

4.32 ± 2.26

0.017

WSWS

53.09 ± 10.69

56.00 ± 12.42

0.246

End of 3 rd month post quit date (Week 12)

   

Breath CO (ppm)

7.30 ± 2.99

1.98 ± 1.25

< 0.001

FTND

4.87 ± 2.10

0.15 ± 0.53

< 0.001

WSWS

51.39 ± 9.81

47.95 ± 10.70

0.123

End of 6 th month post quit date (Week 24)

   

Breath CO (ppm)

8.00 ± 3.58

1.83 ± 2.47

< 0.001

FTND

4.57 ± 1.70

0.25 ± 0.71

< 0.001

WSWS

51.87 ± 9.43

48.20 ± 9.14

0.072

Negative cotinine test (0-10 ng/mL), n (%)

8 (17.4%)

31 (77.5%)

< 0.001‡

  1. * Plus-minus values are means ± SD; †p-values were calculated with the use of independent t-test for all continuous data reporting mean values; ‡p-value was calculated using Chi-square (χ2) test.
  2. FTND = Fagerström test for nicotine dependence; WSWS = Wisconsin smoking withdrawal scale